Connect with us

Bloomberg Technology

Sorrento’s Covid-19 Antibody in Question

May.22 — Sorrento Therapeutics recently said its antibody cocktail has shown 100% inhibition of Covid-19 virus infection, but critics have begun to question its efficacy. Dr. Henry Ji, chairman and chief executive officer at Sorrento Therapeutics, discusses on “Bloomberg Technology.”

Published

on

May.22 — Sorrento Therapeutics recently said its antibody cocktail has shown 100% inhibition of Covid-19 virus infection, but critics have begun to question its efficacy. Dr. Henry Ji, chairman and chief executive officer at Sorrento Therapeutics, discusses on “Bloomberg Technology.”

Continue Reading
Advertisement
25 Comments

25 Comments

  1. Xu Caesar

    May 22, 2020 at 11:51 pm

    CCP Spy!Pay attention!!They want to stole vaccine!!

    • Shaun

      May 23, 2020 at 12:13 am

      Xu Caesar With the whole f—king world trying to come up with a vaccine together, why would the US be hiding their own? For monopoly?

    • Eco Builder

      May 23, 2020 at 7:41 am

      Too late China announced the CURE last night … same thing as DR Henry of SRNE. China tested on humans while FDA is sleeping and not approving Dr henry to move ahead

  2. Fire

    May 23, 2020 at 1:49 am

    pump and dump DONT BUY !!!!

    • DoubleHarmony

      May 23, 2020 at 3:07 am

      Short and Distort don’t fall for it

    • Eco Builder

      May 23, 2020 at 7:39 am

      BUY BUY BUY … China just made the announcement cure found tested on humans. exactly the same thing

  3. Fire

    May 23, 2020 at 1:49 am

    HENRY JI IS A FAILURE !!!!!!

    • DoubleHarmony

      May 23, 2020 at 3:05 am

      Short and Distort attempt, don’t listen to these fools.

    • Eco Builder

      May 23, 2020 at 7:40 am

      AMERICA is first to discover and announce a cure. We are proud of Dr Henry

    • Fire

      May 23, 2020 at 8:49 am

      @Eco Builder he said he doesnt have cure he has antibody LMFAO. he lied !!!!

  4. BasundhiBiryani

    May 23, 2020 at 2:09 am

    It’s just a concept/theory they have, no cure found. Manipulated stock, should be delisted

    • Eco Builder

      May 23, 2020 at 7:37 am

      Listen careful. If you are just infected, you can be cured within 4 days. It can also use as preventive antidode
      But not like vaccine to cure those already suffering from infection long period

  5. Joe Bloe

    May 23, 2020 at 5:42 am

    Good — no Emily Chang!! Taylor is a much better host!

  6. Sadak Vali Syed Vajrakarur

    May 23, 2020 at 6:35 am

    It is pump and dump company I have lost $400 should sue this company announcing COVID19 fake antibody news into market

    • Eco Builder

      May 23, 2020 at 7:35 am

      if you lose money go screw Hindenburg … they short sell to make millions in profit on day one. Cure is real

    • Sadak Vali Syed Vajrakarur

      May 23, 2020 at 7:41 am

      @Eco Builder Not sure who are they ultimately I have lost money which I have hard earned money scooped up by this kind of news so pathetic

  7. M. D

    May 23, 2020 at 7:02 am

    People should not blame poor trading on a company lol I also bought hi but sold and bought lower minimize your risk

  8. Davian's Dad

    May 23, 2020 at 8:17 am

    Back to $10 tomorrow. 🙂

    • ahmet durmaz

      May 23, 2020 at 10:43 am

      Why that

    • Davian's Dad

      May 25, 2020 at 6:48 pm

      ahmet durmaz you didn’t see it go to $10.

  9. Art Of Money

    May 23, 2020 at 3:51 pm

    People need to understand when you invest in Biotech companies make sure you know exactly if they are in Phase 1, Phase 2 or 3. Phase 1 news is only a reaction play for a quick trade. The final product could take months and is for long holders. Pick your time frame and trade it accordingly!

    • thu vu

      May 24, 2020 at 5:32 pm

      When is the good time to invest in?

    • ahmet durmaz

      May 24, 2020 at 6:56 pm

      @thu vu buy now or regret it later

  10. Ajaypal Singh

    May 24, 2020 at 3:53 pm

    People blaming company .. thts funny ???? people tell me how much money you loose when you stocks no matter what you buy. Once a blue moon you make money

  11. Shadow Gallery

    May 25, 2020 at 10:24 pm

    Watch closely. Those who are polarizing….good faith…..pulled out of Novavax for this company….

Leave a Reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

President Trump Announces Apple and Intel Chip Collaboration | Bloomberg Tech 6/18/2026

Bloomberg’s Ed Ludlow discusses the latest announcement made by President Donald Trump, which will see Apple and Intel joining forces to produce chips domestically, sending shares of the chipmaker higher. Plus, Anduril’s CEO discusses how the company won a contract with the US Air Force to produce autonomous fighters. And, SpaceX wraps up its first…

Published

on

Bloomberg’s Ed Ludlow discusses the latest announcement made by President Donald Trump, which will see Apple and Intel joining forces to produce chips domestically, sending shares of the chipmaker higher. Plus, Anduril’s CEO discusses how the company won a contract with the US Air Force to produce autonomous fighters. And, SpaceX wraps up its first full week of trading, with shares falling for a second day straight.

Chapters:
00:00:00 – Bloomberg Tech Begins
00:01:12 – Ian King & Mandeep Singh, Bloomberg News
00:05:57 – Ankur Crawford, Alger
00:12:15 – Brian Schimpf, Anduril
00:20:57 – Matt Day, Bloomberg News
00:23:48 – Michael Regan, Bloomberg News
00:25:56 – Matthew Witheiler, Wellington Management
00:32:23 – Chris Pavolvski, Rumble CEO
00:37:18 – Dana Wollam, Bloomberg News
00:39:49 – Felix Gillette, Bloomberg News
00:41:42 – Randall Williams, Bloomberg News
——–
“Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future of business hosted by Ed Ludlow from San Francisco and Caroline Hyde in New York.

Like this video? Subscribe and turn on the notifications for Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Follow Ed Ludlow on Twitter here:
Follow Caroline Hyde on Twitter here:

Connect with us on…
Twitter:
Facebook:
Instagram:

Continue Reading

Bloomberg Technology

Rumble Bets on AI Compute Demand With New AI Platform

Video platform Rumble is jumping on the AI bandwagon with its newest AI platform. Launching as Quake AI, the new sector combines cloud, compute, and AI infrastructure, and is slated to dominate the company’s business segment. Rumble CEO Chris Pavlovski joins Ed Ludlow on “Bloomberg Tech” with more on the pivot. ——– Like this video?…

Published

on

Video platform Rumble is jumping on the AI bandwagon with its newest AI platform. Launching as Quake AI, the new sector combines cloud, compute, and AI infrastructure, and is slated to dominate the company’s business segment. Rumble CEO Chris Pavlovski joins Ed Ludlow on “Bloomberg Tech” with more on the pivot.
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

Investors Anticipate Fresh Liquidity Following Historic SpaceX Debut

SpaceX’s historic public debut comes during a critical inflection point as a wave of multibillion-dollar AI companies prepare to go public. With the unprecedented IPO, investors are anticipating a wide-scale “distribution event” that will give private markets the fresh cash it desperately needs. Matt Witheiler, Head of Late-Stage Growth at Wellington Management, thinks the private…

Published

on

SpaceX’s historic public debut comes during a critical inflection point as a wave of multibillion-dollar AI companies prepare to go public. With the unprecedented IPO, investors are anticipating a wide-scale “distribution event” that will give private markets the fresh cash it desperately needs. Matt Witheiler, Head of Late-Stage Growth at Wellington Management, thinks the private tech ecosystem will see a cash return. He joins Ed Ludlow of “Bloomberg Tech”.
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Trending